Insider Trading activities of Quest Diagnostics Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Quest Diagnostics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Quest Diagnostics Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Quest Diagnostics Inc since 2005. The reporting company's ticker symbol is DGX. The reporting company's CIK number is 1022079.
The total value of stock buying since 2005 is $1,959,690.
The total value of stock sales since 2005 is $2,281,950,516.
The total value of stock option exercises since 2005 is $205,391,210.


 1   2   3 

Table 2. Detailed insider stock purchases, sales, and option exercises of Quest Diagnostics Inc insiders (DGX) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-10-03 Hagemann Robert (SVP & Chief Financial Officer) Sale 46,667 64.00 2,986,688
2012-10-03 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 46,667 40.43 1,886,653
2012-09-06 Ziegler John B (Director) Sale 10,000 62.32 623,190
2012-09-06 Ziegler John B (Director) Option Ex 10,000 55.40 554,000
2012-08-15 Wilensky Gail R (Director) Sale 20,000 59.24 1,184,720
2012-08-15 Wilensky Gail R (Director) Option Ex 20,000 30.45 609,100
2012-08-10 Buehler William F (Director) Sale 30,000 59.29 1,778,640
2012-08-10 Buehler William F (Director) Option Ex 30,000 42.93 1,287,840
2012-08-08 Doherty Catherine T. (SVP, Physician Services) Sale 40,000 60.11 2,404,320
2012-08-08 Doherty Catherine T. (SVP, Physician Services) Option Ex 40,000 52.23 2,089,400
2012-08-08 Baldwin John C Md (Director) Sale 11,770 59.99 706,082
2012-08-08 Baldwin John C Md (Director) Option Ex 10,000 55.40 554,000
2012-08-07 Rusckowski Stephen H (President and CEO) Buy 5,000 59.34 296,675
2012-08-03 Ziegler John B (Director) Sale 2,800 59.26 165,916
2012-08-01 Prevoznik Michael E (SVP & General Counsel) Sale 86,445 58.68 5,072,333
2012-08-01 Prevoznik Michael E (SVP & General Counsel) Option Ex 86,445 38.50 3,327,959
2012-07-31 Prevoznik Michael E (SVP & General Counsel) Sale 28,814 58.59 1,688,269
2012-07-31 Prevoznik Michael E (SVP & General Counsel) Option Ex 40,222 24.76 995,896
2012-07-12 Stanzione Daniel (Director) Sale 30,000 62.00 1,860,000
2012-07-12 Stanzione Daniel (Director) Option Ex 30,000 42.93 1,287,840
2012-06-29 Bongiorno Thomas F (VP and Corporate Controller) Sale 15,000 59.54 893,100
2012-06-29 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 15,000 52.23 783,525
2012-06-29 Ziegler John B (Director) Sale 1,460 60.00 87,600
2012-06-29 Ziegler John B (Director) Option Ex 1,460 31.12 45,436
2012-06-28 Ziegler John B (Director) Sale 20,000 59.00 1,180,000
2012-06-28 Ziegler John B (Director) Option Ex 20,000 30.45 609,100
2012-05-30 Ziegler John B (Director) Sale 864 58.13 50,224
2012-05-30 Ziegler John B (Director) Option Ex 864 29.35 25,358
2012-05-08 Bongiorno Thomas F (VP and Corporate Controller) Sale 1 56.83 56
2012-05-08 Rusckowski Stephen H (President and CEO) Buy 20,000 56.89 1,137,740
2012-05-02 Pfeiffer Gary M (Director) Sale 10,000 58.30 583,040
2012-05-02 Pfeiffer Gary M (Director) Option Ex 10,000 53.27 532,670
2012-05-01 Baldwin John C Md (Director) Sale 10,334 57.50 594,205
2012-05-01 Baldwin John C Md (Director) Option Ex 8,000 49.94 399,520
2012-05-01 Bongiorno Thomas F (VP and Corporate Controller) Sale 2,305 58.43 134,685
2012-04-02 Hagemann Robert (SVP & Chief Financial Officer) Sale 46,666 62.00 2,893,292
2012-04-02 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 46,666 40.43 1,886,613
2012-03-01 Prevoznik Michael E (SVP & General Counsel) Sale 7,207 57.40 413,652
2012-02-24 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Sale 15,561 57.45 893,979
2012-02-24 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Option Ex 15,561 56.23 875,072
2012-02-21 Bongiorno Thomas F (VP and Corporate Controller) Sale 7,078 57.50 406,985
2012-02-21 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 7,078 56.87 402,554
2012-02-16 Prevoznik Michael E (SVP & General Counsel) Sale 1,462 57.38 83,888
2012-02-14 Prevoznik Michael E (SVP & General Counsel) Sale 4,544 57.39 260,784
2012-02-03 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Sale 13,333 58.50 779,980
2012-02-03 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Option Ex 13,333 55.65 741,981
2012-02-01 Mohapatra Surya N (Chairman, President & CEO) Sale 20,556 58.38 1,200,018
2012-02-01 Mohapatra Surya N (Chairman, President & CEO) Option Ex 20,556 48.74 1,001,899
2012-01-30 Mohapatra Surya N (Chairman, President & CEO) Sale 90,000 58.17 5,235,480
2012-01-27 Mohapatra Surya N (Chairman, President & CEO) Sale 119,732 59.04 7,068,977
2012-01-27 Mohapatra Surya N (Chairman, President & CEO) Option Ex 119,732 40.43 4,840,525
2012-01-27 Stanzione Daniel (Director) Sale 30,000 59.00 1,770,000
2012-01-27 Stanzione Daniel (Director) Option Ex 30,000 50.37 1,510,980
2012-01-27 Wilensky Gail R (Director) Sale 30,000 58.94 1,768,140
2012-01-27 Wilensky Gail R (Director) Option Ex 30,000 50.37 1,510,980
2012-01-26 Baldwin John C Md (Director) Sale 10,000 59.00 590,010
2012-01-26 Baldwin John C Md (Director) Option Ex 10,000 53.27 532,670
2012-01-26 Hagemann Robert (SVP & Chief Financial Officer) Sale 113,334 59.37 6,728,979
2012-01-26 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 113,334 52.23 5,920,001
2012-01-26 Mohapatra Surya N (Chairman, President & CEO) Sale 220,268 59.12 13,022,464
2012-01-26 Mohapatra Surya N (Chairman, President & CEO) Option Ex 220,268 40.43 8,904,994
2012-01-26 Buehler William F (Director) Sale 30,000 58.83 1,764,780
2012-01-26 Buehler William F (Director) Option Ex 30,000 50.37 1,510,980
2012-01-03 Mohapatra Surya N (Chairman, President & CEO) Sale 20,556 58.66 1,205,856
2012-01-03 Mohapatra Surya N (Chairman, President & CEO) Option Ex 20,556 48.74 1,001,899
2011-12-21 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 57.75 239,658
2011-12-21 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-12-01 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 58.16 241,368
2011-12-01 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-12-01 Mohapatra Surya N (Chairman, President & CEO) Sale 20,556 57.95 1,191,179
2011-12-01 Mohapatra Surya N (Chairman, President & CEO) Option Ex 20,556 48.74 1,001,899
2011-11-21 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 54.40 225,760
2011-11-21 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-11-08 Bongiorno Thomas F (VP and Corporate Controller) Sale 13,334 57.50 766,705
2011-11-08 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 13,334 48.74 649,899
2011-11-03 Britell Jenne K (Director) Sale 7,500 55.70 417,750
2011-11-03 Britell Jenne K (Director) Option Ex 7,500 47.45 355,875
2011-11-01 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 54.81 227,457
2011-11-01 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-11-01 Mohapatra Surya N (Chairman, President & CEO) Sale 20,556 54.69 1,124,145
2011-11-01 Mohapatra Surya N (Chairman, President & CEO) Option Ex 20,556 48.74 1,001,899
2011-10-28 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Sale 19,259 57.50 1,107,392
2011-10-28 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Option Ex 19,259 52.23 1,005,993
2011-10-28 Ziegler John B (Director) Sale 12,997 57.28 744,494
2011-10-28 Ziegler John B (Director) Option Ex 12,997 52.38 680,795
2011-10-28 Mohapatra Surya N (Chairman, President & CEO) Sale 50,000 57.41 2,870,500
2011-10-28 Mohapatra Surya N (Chairman, President & CEO) Option Ex 50,000 24.76 1,238,000
2011-10-27 Prevoznik Michael E (SVP & General Counsel) Sale 116,000 56.68 6,574,880
2011-10-27 Prevoznik Michael E (SVP & General Counsel) Option Ex 116,000 42.14 4,887,776
2011-10-25 Mohapatra Surya N (Chairman, President & CEO) Sale 48,047 56.49 2,714,175
2011-10-25 Mohapatra Surya N (Chairman, President & CEO) Option Ex 48,047 48.74 2,341,810
2011-10-21 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 49.29 204,553
2011-10-21 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-10-03 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 49.23 204,300
2011-10-03 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-09-21 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 49.51 205,478
2011-09-21 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-09-01 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 49.97 207,383
2011-09-01 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-08-29 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 49.00 203,350
2011-08-29 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-08-17 Bongiorno Thomas F (VP and Corporate Controller) Sale 1,500 49.29 73,938
2011-07-21 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 57.19 237,350
2011-07-21 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-07-01 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 58.99 244,804
2011-07-01 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-07-01 Mohapatra Surya N (Chairman, President & CEO) Sale 20,555 58.96 1,211,963
2011-07-01 Mohapatra Surya N (Chairman, President & CEO) Option Ex 20,555 48.74 1,001,850
2011-06-21 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 60.67 251,801
2011-06-21 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-06-16 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Sale 3,815 60.20 229,663
2011-06-16 Simmons Wayne R. (Vice President, Operations) Sale 16,000 60.00 960,000
2011-06-16 Simmons Wayne R. (Vice President, Operations) Option Ex 16,000 48.74 779,840
2011-06-14 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Sale 4,668 59.70 278,679
2011-06-13 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Sale 10,615 59.20 628,408
2011-06-01 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 58.10 241,110
2011-06-01 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-06-01 Mohapatra Surya N (Chairman, President & CEO) Sale 20,555 58.06 1,193,505
2011-06-01 Mohapatra Surya N (Chairman, President & CEO) Option Ex 20,555 48.74 1,001,850
2011-05-23 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 57.46 238,471
2011-05-23 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-05-18 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Sale 21,112 58.10 1,226,607
2011-05-18 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Option Ex 21,112 47.49 1,002,608
2011-05-17 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Sale 1,809 57.93 104,795
2011-05-12 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Sale 42,365 57.52 2,436,961
2011-05-12 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Option Ex 40,555 47.49 1,925,956
2011-05-11 Simmons Wayne R. (Vice President, Operations) Sale 10,000 57.00 570,000
2011-05-02 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 56.46 234,300
2011-05-02 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-05-02 Mohapatra Surya N (Chairman, President & CEO) Sale 20,555 56.68 1,165,139
2011-05-02 Mohapatra Surya N (Chairman, President & CEO) Option Ex 20,555 48.74 1,001,850
2011-04-21 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 58.28 241,862
2011-04-21 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-04-01 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 57.78 239,803
2011-04-01 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-04-01 Mohapatra Surya N (Chairman, President & CEO) Sale 20,555 57.70 1,185,982
2011-04-01 Mohapatra Surya N (Chairman, President & CEO) Option Ex 20,555 48.74 1,001,850
2011-03-21 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 54.19 224,900
2011-03-21 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-03-09 Prevoznik Michael E (SVP & General Counsel) Sale 2,596 57.50 149,267
2011-03-01 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 56.77 235,595
2011-03-01 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-03-01 Mohapatra Surya N (Chairman, President & CEO) Sale 20,555 56.75 1,166,537
2011-03-01 Mohapatra Surya N (Chairman, President & CEO) Option Ex 20,555 48.74 1,001,850
2011-02-18 Prevoznik Michael E (SVP & General Counsel) Sale 8,685 57.46 499,048
2011-02-16 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Sale 26,666 57.40 1,530,628
2011-02-16 Miller Joan Elizabeth (SVP-Pathology & Hosp. Services) Option Ex 26,666 48.74 1,299,700
2011-02-15 Prevoznik Michael E (SVP & General Counsel) Sale 1,540 57.17 88,041
2011-02-14 Prevoznik Michael E (SVP & General Counsel) Sale 1,503 57.17 85,922
2011-02-11 Prevoznik Michael E (SVP & General Counsel) Sale 18,457 57.19 1,055,555
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of DGX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Quest Diagnostics Inc (symbol DGX, CIK number 1022079) see the Securities and Exchange Commission (SEC) website.